Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q2 2023 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q2 2023 Earnings Call Transcript August 1, 2023

Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.8.

Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please...